Home / DAVA : NYSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does DAVA make money? Does DAVA have pricing power? What's the Earnings Whisper? Will DAVA profit more as the business scales? What is DAVA's management track record? Is DAVA's current price justified?

Endava plc

$2.91 -$3.18 (-52.22%)

NYSE · 11 Sep 2026 20:00 UTC

Previous Close

$2.83

Day Range

$2.86$2.91

Year Range

$2.55$10

Market Cap

155.9M

AVG Volume

336.33K

Trailing/Forward PE

-0.27/4.91

PEG ratio

-0.01

Dividend Yield

Next Earnings Date

2026-09-17

Primary Exchange

New York Stock Exchange

Revenue (GBP)

DAVA Revenue (GBP) by year
Period	Revenue (GBP)
2025	772.25M
2024	740.76M
2023	794.73M
2022	654.76M
2021	446.3M
2020	350.95M
2019	287.93M
2018	217.61M

Net Income (GBP)

DAVA Net Income (GBP) by year
Period	Net Income (GBP)
2025	21.21M
2024	17.12M
2023	94.16M
2022	83.09M
2021	43.44M
2020	21.41M
2019	24.01M
2018	18.98M

Operating Income (GBP)

DAVA Operating Income (GBP) by year
Period	Operating Income (GBP)
2025	31.51M
2024	20.14M
2023	112.84M
2022	95.38M
2021	63.54M
2020	21.87M
2019	32.97M
2018	25.43M

EBITDA (GBP)

DAVA EBITDA (GBP) by year
Period	EBITDA (GBP)
2025	79.58M
2024	71.32M
2023	165.06M
2022	126.24M
2021	76.25M
2020	38.81M
2019	38.34M
2018	31.73M

Cash Flows (GBP)

DAVA Cash Flows (GBP) by year
Period	Cash Flows (GBP)
2025	48.07M
2024	48.91M
2023	110.84M
2022	106.75M
2021	82.24M
2020	30.36M
2019	27.96M
2018	28.5M

EPS (GBP)

DAVA EPS (GBP) by year
Period	EPS (GBP)
2025	0.35
2024	0.29
2023	1.63
2022	1.45
2021	0.77
2020	0.38
2019	0.44
2018	0.37

Expenses (GBP)

DAVA Expenses (GBP) by year
Period	Expenses (GBP)
2025	4.7M
2024	5.49M
2023	122.47M
2022	105.79M
2021	32.99M
2020	47.2M
2019	72.27M
2018	52.23M

Cash & Debt (GBP)

DAVA Cash & Debt (GBP) by year
Period	Cash & Debt (GBP)
2025	59.47M
2024	62.54M
2023	164.76M
2022	163.2M
2021	70.45M
2020	101.91M
2019	70.17M
2018	15.05M

Debt ratios

DAVA Debt ratios by year
Period	Debt ratios
2025	0.38
2024	0.32
2023	-0.24
2022	-0.38
2021	-0.04

Margins

DAVA Margins by year
Period	Margins
2025	25.65%
2024	25.49%
2023	33.23%
2022	33.28%
2021	34.47%
2020	28.54%
2019	34.32%
2018	33.16%

Return on Capital

DAVA Return on Capital by year
Period	Return on Capital
2025	3.64%
2024	2.68%
2023	16.48%
2022	19.2%
2021	14.45%
2020	9.06%
2019	14.43%
2018	27.3%

Shares Outstanding

DAVA Shares Outstanding by year
Period	Shares Outstanding
2025	59.16M
2024	58.44M
2023	57.73M
2022	56.68M
2021	55.64M
2020	54.18M
2019	52.37M
2018	49.36M

Book Value Per Share (GBP)

DAVA Book Value Per Share (GBP) by year
Period	Book Value Per Share (GBP)
2025	9.85
2024	10.94
2023	9.9
2022	7.63
2021	5.4
2020	4.36
2019	3.18
2018	1.41

Total Assets (GBP)

DAVA Total Assets (GBP) by year
Period	Total Assets (GBP)
2025	935.77M
2024	1.01B
2023	770.12M
2022	621.86M
2021	473.21M
2020	360.94M
2019	222.68M
2018	151.01M

Employee Count

DAVA Employee Count by year
Period	Employee Count
2025	11.48K
2024	12.09K
2023	12.06K
2022	153
2021	142
2020	6.62K
2019	5.75K
2018	62

PE Ratio

DAVA PE Ratio by year
Period	PE Ratio
Mar 26	16.06
Mar 26	16.84
Mar 26	18.06
Mar 26	20.12
Feb 26	17.03
Feb 26	17.98
Feb 26	18.33
Feb 26	19.68
Jan 26	22.66
Jan 26	25.14
Jan 26	24.43
Jan 26	25.33
Jan 26	22.21
Dec 25	24.06
Dec 25	25.09
Dec 25	24.37
Dec 25	24.81
Nov 25	23.95
Nov 25	23.6
Nov 25	24.44
Nov 25	19.7
Oct 25	19.72
Oct 25	19.82
Oct 25	17.58
Oct 25	17.35
Oct 25	19.04
Sep 25	18.5
Sep 25	19.11
Sep 25	20.31
Sep 25	21.02
Aug 25	35.36
Aug 25	32.93
Aug 25	30.21
Aug 25	30.2
Aug 25	29.25
Jul 25	36.18
Jul 25	32.88
Jul 25	33.08
Jul 25	36.92
Jun 25	35.57
Jun 25	33.66
Jun 25	37.55
Jun 25	39.63
May 25	37.33
May 25	34
May 25	36.9
May 25	161.78
May 25	154.11
Apr 25	149.13
Apr 25	139.25
Apr 25	148.18
Apr 25	146.23
Mar 25	166.47
Mar 25	180.52
Mar 25	174.75
Mar 25	193.19
Feb 25	205.44
Feb 25	222.57
Feb 25	226.86
Feb 25	225.34
Jan 25	218.3
Jan 25	215.27
Jan 25	216.34
Jan 25	213.23
Jan 25	209.99
Dec 24	202.3
Dec 24	201.27
Dec 24	198.36
Dec 24	196.78
Nov 24	185.47
Nov 24	78.09
Nov 24	72.7
Nov 24	69.66
Nov 24	62.63
Oct 24	65.36
Oct 24	69.85
Oct 24	64.53
Oct 24	65.98
Sep 24	66.74
Sep 24	68.19
Sep 24	35.43
Sep 24	32.22
Aug 24	33.86
Aug 24	33.01
Aug 24	31.91
Aug 24	30.93
Aug 24	32.19
Jul 24	33.5
Jul 24	33.62
Jul 24	33.5
Jul 24	31.97
Jun 24	32.15
Jun 24	31.19
Jun 24	27.9
Jun 24	28.67
May 24	29.39
May 24	32.78
May 24	19.54
May 24	20.83
May 24	21.07

Free Cash Flow Yield

DAVA Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	15.75%
Sep 26	14.97%
Aug 26	14.29%
Aug 26	14.49%
Aug 26	14.79%
Aug 26	15.49%
Jul 26	15.27%
Jul 26	16.96%
Jul 26	16.16%
Jul 26	16.57%
Jul 26	15.02%
Jun 26	15.74%
Jun 26	16.89%
Jun 26	15.66%
Jun 26	16.2%
May 26	14.16%
May 26	13.67%
May 26	26.61%
May 26	25.32%
May 26	24.97%
Apr 26	23.92%
Apr 26	21.42%
Apr 26	24.64%
Apr 26	22.39%
Mar 26	31.11%
Mar 26	29.66%
Mar 26	27.65%
Mar 26	24.83%
Feb 26	29.33%
Feb 26	27.78%
Feb 26	27.26%
Feb 26	25.38%
Jan 26	22.04%
Jan 26	19.87%
Jan 26	20.45%
Jan 26	19.72%
Jan 26	22.5%
Dec 25	20.76%
Dec 25	19.91%
Dec 25	20.5%
Dec 25	20.14%
Nov 25	20.86%
Nov 25	21.17%
Nov 25	20.44%
Nov 25	11.5%
Oct 25	11.49%
Oct 25	11.43%
Oct 25	12.89%
Oct 25	13.06%
Oct 25	11.9%
Sep 25	12.25%
Sep 25	11.86%
Sep 25	11.16%
Sep 25	10.78%
Aug 25	7.79%
Aug 25	8.37%
Aug 25	9.12%
Aug 25	9.12%
Aug 25	9.42%
Jul 25	7.61%
Jul 25	8.38%
Jul 25	8.33%
Jul 25	7.46%
Jun 25	7.75%
Jun 25	8.18%
Jun 25	7.34%
Jun 25	6.95%
May 25	7.38%
May 25	8.1%
May 25	7.47%
May 25	3.85%
May 25	4.05%
Apr 25	4.18%
Apr 25	4.48%
Apr 25	4.21%
Apr 25	4.26%
Mar 25	3.75%
Mar 25	3.45%
Mar 25	3.57%
Mar 25	3.23%
Feb 25	3.03%
Feb 25	2.8%
Feb 25	2.29%
Feb 25	2.3%
Jan 25	2.38%
Jan 25	2.41%
Jan 25	2.4%
Jan 25	2.44%
Jan 25	2.47%
Dec 24	2.57%
Dec 24	2.58%
Dec 24	2.62%
Dec 24	2.64%
Nov 24	2.8%
Nov 24	3.66%
Nov 24	3.93%
Nov 24	4.1%
Nov 24	4.56%
Oct 24	4.37%
Oct 24	4.09%

Price to Sales

DAVA Price to Sales by year
Period	Price to Sales
Sep 26	0.15
Sep 26	0.16
Aug 26	0.17
Aug 26	0.17
Aug 26	0.16
Aug 26	0.16
Jul 26	0.16
Jul 26	0.14
Jul 26	0.15
Jul 26	0.15
Jul 26	0.16
Jun 26	0.15
Jun 26	0.14
Jun 26	0.15
Jun 26	0.15
May 26	0.17
May 26	0.18
May 26	0.21
May 26	0.22
May 26	0.22
Apr 26	0.23
Apr 26	0.26
Apr 26	0.22
Apr 26	0.24
Mar 26	0.23
Mar 26	0.24
Mar 26	0.26
Mar 26	0.29
Feb 26	0.24
Feb 26	0.26
Feb 26	0.26
Feb 26	0.28
Jan 26	0.32
Jan 26	0.36
Jan 26	0.35
Jan 26	0.36
Jan 26	0.32
Dec 25	0.34
Dec 25	0.36
Dec 25	0.35
Dec 25	0.35
Nov 25	0.34
Nov 25	0.34
Nov 25	0.35
Nov 25	0.54
Oct 25	0.54
Oct 25	0.54
Oct 25	0.48
Oct 25	0.48
Oct 25	0.52
Sep 25	0.51
Sep 25	0.52
Sep 25	0.56
Sep 25	0.58
Aug 25	0.82
Aug 25	0.77
Aug 25	0.7
Aug 25	0.7
Aug 25	0.68
Jul 25	0.84
Jul 25	0.77
Jul 25	0.77
Jul 25	0.86
Jun 25	0.83
Jun 25	0.79
Jun 25	0.88
Jun 25	0.92
May 25	0.87
May 25	0.79
May 25	0.86
May 25	1.17
May 25	1.12
Apr 25	1.08
Apr 25	1.01
Apr 25	1.07
Apr 25	1.06
Mar 25	1.21
Mar 25	1.31
Mar 25	1.27
Mar 25	1.4
Feb 25	1.49
Feb 25	1.61
Feb 25	2.13
Feb 25	2.11
Jan 25	2.05
Jan 25	2.02
Jan 25	2.03
Jan 25	2
Jan 25	1.97
Dec 24	1.9
Dec 24	1.89
Dec 24	1.86
Dec 24	1.84
Nov 24	1.74
Nov 24	1.8
Nov 24	1.68
Nov 24	1.61
Nov 24	1.45
Oct 24	1.51
Oct 24	1.61

EV/EBITDA

DAVA EV/EBITDA by year
Period	EV/EBITDA
May 26	6.36
May 26	6.5
May 26	6.53
Apr 26	6.66
Apr 26	7
Apr 26	6.57
Apr 26	6.86
Mar 26	5.7
Mar 26	5.83
Mar 26	6.04
Mar 26	6.38
Feb 26	5.87
Feb 26	6.03
Feb 26	6.08
Feb 26	6.31
Jan 26	6.81
Jan 26	7.22
Jan 26	7.1
Jan 26	7.25
Jan 26	6.73
Dec 25	7.04
Dec 25	7.21
Dec 25	7.09
Dec 25	7.17
Nov 25	7.02
Nov 25	6.97
Nov 25	7.1
Nov 25	7.37
Oct 25	7.38
Oct 25	7.4
Oct 25	6.8
Oct 25	6.74
Oct 25	7.19
Sep 25	7.05
Sep 25	7.21
Sep 25	7.53
Sep 25	7.72
Aug 25	9.57
Aug 25	9.02
Aug 25	8.39
Aug 25	8.39
Aug 25	8.17
Jul 25	9.76
Jul 25	9
Jul 25	9.05
Jul 25	9.93
Jun 25	9.62
Jun 25	9.18
Jun 25	10.07
Jun 25	10.55
May 25	10.02
May 25	9.26
May 25	9.92
May 25	16.49
May 25	15.79
Apr 25	15.35
Apr 25	14.45
Apr 25	15.26
Apr 25	15.08
Mar 25	16.91
Mar 25	18.18
Mar 25	17.66
Mar 25	19.32
Feb 25	20.42
Feb 25	21.97
Feb 25	28.09
Feb 25	27.91
Jan 25	27.11
Jan 25	26.76
Jan 25	26.89
Jan 25	26.53
Jan 25	26.16
Dec 24	25.28
Dec 24	25.17
Dec 24	24.83
Dec 24	24.65
Nov 24	23.36
Nov 24	20.71
Nov 24	19.42
Nov 24	18.69
Nov 24	17
Oct 24	17.66
Oct 24	18.73
Oct 24	17.46
Oct 24	17.81
Sep 24	17.99
Sep 24	18.34
Sep 24	15.75
Sep 24	14.18
Aug 24	14.99
Aug 24	14.57
Aug 24	14.04
Aug 24	13.55
Aug 24	14.17
Jul 24	14.81
Jul 24	14.87
Jul 24	14.81
Jul 24	14.06
Jun 24	14.15
Jun 24	13.68

Price/Operating Cashflow

DAVA Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	3.36
Sep 26	3.53
Aug 26	3.7
Aug 26	3.65
Aug 26	3.57
Aug 26	3.41
Jul 26	3.46
Jul 26	3.12
Jul 26	3.27
Jul 26	3.19
Jul 26	3.52
Jun 26	3.36
Jun 26	3.13
Jun 26	3.38
Jun 26	3.26
May 26	3.74
May 26	3.87
May 26	2.78
May 26	2.93
May 26	2.97
Apr 26	3.1
Apr 26	3.46
Apr 26	3.01
Apr 26	3.31
Mar 26	2.86
Mar 26	3
Mar 26	3.22
Mar 26	3.59
Feb 26	3.04
Feb 26	3.2
Feb 26	3.27
Feb 26	3.51
Jan 26	4.04
Jan 26	4.48
Jan 26	4.35
Jan 26	4.51
Jan 26	3.96
Dec 25	4.29
Dec 25	4.47
Dec 25	4.34
Dec 25	4.42
Nov 25	4.27
Nov 25	4.21
Nov 25	4.35
Nov 25	7.92
Oct 25	7.93
Oct 25	7.97
Oct 25	7.07
Oct 25	6.98
Oct 25	7.65
Sep 25	7.44
Sep 25	7.68
Sep 25	8.16
Sep 25	8.45
Aug 25	11.73
Aug 25	10.92
Aug 25	10.02
Aug 25	10.02
Aug 25	9.7
Jul 25	12
Jul 25	10.91
Jul 25	10.97
Jul 25	12.25
Jun 25	11.8
Jun 25	11.17
Jun 25	12.46
Jun 25	13.14
May 25	12.38
May 25	11.28
May 25	12.24
May 25	22.73
May 25	21.66
Apr 25	20.96
Apr 25	19.57
Apr 25	20.82
Apr 25	20.55
Mar 25	23.39
Mar 25	25.37
Mar 25	24.56
Mar 25	27.15
Feb 25	28.87
Feb 25	31.28
Feb 25	37.67
Feb 25	37.41
Jan 25	36.25
Jan 25	35.74
Jan 25	35.92
Jan 25	35.4
Jan 25	34.86
Dec 24	33.59
Dec 24	33.42
Dec 24	32.93
Dec 24	32.67
Nov 24	30.79
Nov 24	24.58
Nov 24	22.88
Nov 24	21.93
Nov 24	19.72
Oct 24	20.58
Oct 24	21.99

Price to Book

DAVA Price to Book by year
Period	Price to Book
Sep 26	0.65
Sep 26	0.68
Aug 26	0.72
Aug 26	0.71
Aug 26	0.69
Aug 26	0.66
Jul 26	0.67
Jul 26	0.6
Jul 26	0.63
Jul 26	0.62
Jul 26	0.68
Jun 26	0.65
Jun 26	0.61
Jun 26	0.65
Jun 26	0.63
May 26	0.72
May 26	0.75
May 26	0.27
May 26	0.28
May 26	0.29
Apr 26	0.3
Apr 26	0.34
Apr 26	0.29
Apr 26	0.32
Mar 26	0.31
Mar 26	0.32
Mar 26	0.34
Mar 26	0.38
Feb 26	0.32
Feb 26	0.34
Feb 26	0.35
Feb 26	0.37
Jan 26	0.43
Jan 26	0.48
Jan 26	0.46
Jan 26	0.48
Jan 26	0.42
Dec 25	0.46
Dec 25	0.48
Dec 25	0.46
Dec 25	0.47
Nov 25	0.46
Nov 25	0.45
Nov 25	0.46
Nov 25	0.72
Oct 25	0.72
Oct 25	0.72
Oct 25	0.64
Oct 25	0.63
Oct 25	0.69
Sep 25	0.67
Sep 25	0.7
Sep 25	0.74
Sep 25	0.76
Aug 25	1
Aug 25	0.93
Aug 25	0.85
Aug 25	0.85
Aug 25	0.82
Jul 25	1.02
Jul 25	0.93
Jul 25	0.93
Jul 25	1.04
Jun 25	1
Jun 25	0.95
Jun 25	1.06
Jun 25	1.12
May 25	1.05
May 25	0.96
May 25	1.04
May 25	1.36
May 25	1.3
Apr 25	1.25
Apr 25	1.17
Apr 25	1.25
Apr 25	1.23
Mar 25	1.4
Mar 25	1.52
Mar 25	1.47
Mar 25	1.63
Feb 25	1.73
Feb 25	1.87
Feb 25	2.54
Feb 25	2.52
Jan 25	2.44
Jan 25	2.41
Jan 25	2.42
Jan 25	2.38
Jan 25	2.35
Dec 24	2.26
Dec 24	2.25
Dec 24	2.22
Dec 24	2.2
Nov 24	2.07
Nov 24	2.09
Nov 24	1.95
Nov 24	1.87
Nov 24	1.68
Oct 24	1.75
Oct 24	1.87

No video analysis for this stock yet. Request one from our team.

News: DAVA

globenewswire.com · 12 Aug 2026

LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology's 4th Summit on Breast Cancer

BOTHELL, Wash., Aug. 12, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that its lead product candidate, lasofoxifene, will be featured in multiple presentations at Dava Oncology's 4th Summit on Breast Cancer taking place from August 18-22, 2026, in Kona, Hawaii.

businesswire.com · 30 Jun 2026

Endava Partners with Wiz to Deliver Integrated Cloud Security for Enterprise AI Adoption

LONDON--(BUSINESS WIRE)--Endava (NYSE ‘DAVA'), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced a collaboration with Wiz, the leading cloud and AI security platform that is now part of Google Cloud. Building on Endava's status as both a Google Cloud Premier Partner and Google Security Partner, Endava has now joined the Wiz Partner Alliance, a global community of partners united by one goal.

AI Analysis

Endava plc

Video analysis: DAVA

News: DAVA

LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology's 4th Summit on Breast Cancer

Endava Partners with Wiz to Deliver Integrated Cloud Security for Enterprise AI Adoption

Similar companies